Pharmaceutical Supply Chain Challenges

This chapter examines the supply chain issues affecting Novo Nordisk and Eli Lilly's weight loss medications, highlighting drug shortages and upcoming litigation. It also considers the potential impact of new oral treatments and changing health insurance coverage on patients and the pharmaceutical industry amidst political uncertainties.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.